Evaluating Gentian Violet as a Low-Cost Alternative for Sentinel Lymph Node Biopsy in Breast Cancer: A Single-Center Retrospective Study. (2026)

Peer-Reviewed Study · Mooghal M, Ali ZM, Saleem L, Yaqoob A, Ahmad F, Jamal A · January 9, 2026

Mooghal M et al., 2026-01-09: Pakistani retrospective study of 40 breast cancer patients mapped with gentian violet plus radioisotope, reporting 97.5% detection and concluding gentian violet is a safe, affordable alternative to methylene blue; methylene blue was not tested in the study.

Standard tracers such as vital blue dye (VBD), methylene blue (MB), and radioisotopes (RIs) are effective but costly and logistically challenging.

Mooghal M et al., 2026-01-09: Pakistani retrospective study of 40 breast cancer patients mapped with gentian violet plus radioisotope, reporting 97.5% detection and concluding gentian violet is a safe, affordable alternative to methylene blue; methylene blue was not tested in the study. C7 (comparator). Study type: single-centre retrospective study; Cancer Foundation Hospital, Karachi, Pakistan. N not stated in the abstract. Gentian violet reported as having high detection rates and excellent safety, described as a viable alternative to methylene blue. Dose not stated. Funder/conflicts not stated in the abstract. PARTLY: methylene blue works, but a cheaper dye is reported as comparable, which bears on the 'dye of choice' framing. Asia Pac J Clin Oncol 2026 (volume/pages not yet assigned). Study type: uncontrolled series.